Drugs / Autologous Plasma Eye Drop
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03768115 | Nov 2018 → Oct 2020 | dry eye syndrome | Singapore National Eye Centre | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Plasma Eye Drop | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03768115 ↗ |
| Route | Topical | “Patients will use autologous plasma only for application as eye drops.” NCT03768115 ↗ |